−0.0151 USD
−610.04 K USD
766.84 K USD
94.66 M
About PharmAla Biotech Holdings, Inc.
Sector
Industry
CEO
Nicholas Kadysh
Website
Headquarters
Toronto
ISIN
CA71719L1067
FIGI
BBG01GHNMNF3
PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDXXF is 0.0840 USD — it has decreased by −19.62% in the past 24 hours. Watch PharmAla Biotech Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PharmAla Biotech Holdings Inc. stocks are traded under the ticker MDXXF.
MDXXF stock has fallen by −9.64% compared to the previous week, the month change is a −13.49% fall, over the last year PharmAla Biotech Holdings Inc. has showed a 32.28% increase.
MDXXF reached its all-time high on Jun 29, 2023 with the price of 0.3600 USD, and its all-time low was 0.0401 USD and was reached on Aug 12, 2024. View more price dynamics on MDXXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDXXF stock is 24.40% volatile and has beta coefficient of 1.84. Track PharmAla Biotech Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is PharmAla Biotech Holdings Inc. there?
Today PharmAla Biotech Holdings Inc. has the market capitalization of 8.41 M, it has increased by 8.85% over the last week.
Yes, you can track PharmAla Biotech Holdings Inc. financials in yearly and quarterly reports right on TradingView.
MDXXF net income for the last quarter is −381.28 K USD, while the quarter before that showed −560.13 K USD of net income which accounts for 31.93% change. Track more PharmAla Biotech Holdings Inc. financial stats to get the full picture.
No, MDXXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PharmAla Biotech Holdings Inc. EBITDA is −1.37 M USD, and current EBITDA margin is −57.56%. See more stats in PharmAla Biotech Holdings Inc. financial statements.
Like other stocks, MDXXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PharmAla Biotech Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PharmAla Biotech Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PharmAla Biotech Holdings Inc. stock shows the sell signal. See more of PharmAla Biotech Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.